|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 212.17 USD | +0.54% |
|
-10.99% | +16.17% |
| 31/07 | Mizuho Trims Price Target on Axsome Therapeutics to $306 From $310, Keeps Outperform Rating | MT |
| 21/07 | BMO Capital Initiates Axsome Therapeutics at Outperform With $310 Price Target | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.54% | -10.99% | -13.16% | +2.73% | +16.17% | +105.95% | +181.84% | +331.42% | +2,644.76% | 1.09TCr | |
| +0.19% | +14.01% | +16.26% | +8.45% | -1.45% | +36.11% | -1.40% | +29.69% | +72.34% | 7.58TCr | |
| +0.86% | -9.15% | -13.95% | -3.42% | -6.41% | +20.80% | +181.80% | +139.85% | +222.78% | 4.86TCr | |
| +3.72% | -4.47% | +3.87% | +0.41% | -12.92% | -7.16% | +18.96% | +5.61% | - | 4.6TCr | |
| +3.64% | +10.69% | +5.76% | +3.20% | -25.38% | -51.21% | -51.75% | -56.23% | +10.30% | 4.17TCr | |
| +3.29% | +4.15% | -3.55% | +11.43% | +18.44% | +57.98% | -22.15% | -38.33% | -35.13% | 2.98TCr | |
| +1.83% | +1.46% | +3.20% | +24.45% | +22.10% | +59.54% | +85.60% | +54.71% | +32.80% | 2.4TCr | |
| +3.36% | +2.44% | -28.55% | +25.61% | +93.25% | +106.45% | -48.17% | -85.26% | - | 2.2TCr | |
| +0.81% | -2.97% | -1.25% | -3.67% | +13.70% | -6.77% | +164.33% | +8.10% | - | 1.91TCr | |
| +0.05% | -5.99% | -8.94% | +1.96% | +31.07% | +64.98% | +113.20% | +160.57% | +306.52% | 1.58TCr | |
| +2.64% | -2.44% | +6.32% | +19.71% | +7.30% | +73.25% | +155.67% | +55.47% | - | 1.56TCr | |
| +1.21% | +0.75% | +2.93% | +12.32% | +2.17% | +4.44% | -30.80% | -21.80% | -40.15% | 1.16TCr | |
| +9.29% | +11.22% | +1.61% | -5.83% | -22.80% | -17.77% | +652.71% | +409.67% | +5,597.61% | 1.19TCr | |
| +3.90% | -7.69% | -13.41% | +22.08% | +31.73% | +106.89% | +160.69% | +458.02% | - | 925.17Cr | |
| +1.39% | +3.60% | +13.11% | +13.84% | -4.67% | -21.08% | -20.37% | -51.70% | -46.78% | 691.52Cr | |
| +3.12% | +8.21% | +14.77% | +18.95% | +2.84% | +14.77% | +62.00% | -7.15% | - | 598.01Cr | |
| +3.51% | +19.60% | +17.76% | +37.49% | +84.22% | +137.62% | +304.20% | +455.08% | - | 572.77Cr | |
| -1.26% | +4.73% | +6.67% | -22.32% | -32.06% | -47.42% | -55.21% | -78.92% | - | 578.66Cr | |
| -1.60% | +14.91% | +0.21% | +64.64% | +213.51% | +195.26% | +381.11% | -16.45% | - | 629.31Cr | |
| +4.08% | -5.04% | -31.46% | -17.54% | +1.31% | +13.69% | +208.69% | +198.61% | - | 530.48Cr | |
| Average | +2.19% | +1.92% | -1.09% | +10.72% | +21.61% | +42.32% | +122.05% | +97.55% | +876.51% | 2.09TCr | |
| Weighted average by Cap. | +2.08% | +2.15% | +0.45% | +7.90% | +9.05% | +30.07% | +74.52% | +57.33% | +417.96% |
- Stock Market
- Stocks
- AXSM Stock
- Sector Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
